Use

This test is used to monitor serum concentration of levetiracetam, particularly in patients with kidney disease. It is also used to assess compliance with levetiracetam therapy and for assessing potential toxicity of levetiracetam. Levetiracetam is used to treat partial, myoclonic, and tonic-clonic seizures. It has favorable pharmacokinetics with good bioavailability, minimal hepatic metabolism, and is excreted renally. Monitoring is essential for dose adjustment in kidney dysfunction and to ensure therapeutic levels are maintained.